Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow ALGN
Align Technology, Inc. (ALGN) Total debt
Align Technology, Inc.'s total debt at the end of fiscal 2022 was $127.0M, unchanged from fiscal 2021. At the end of the quarter to 30 September 2023 it was $127.0M. Align Technology, Inc. ranks 22nd of 54 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $127.0M | 0.79% |
| FY2021 | $126.0M | 46.51% |
| FY2020 | $86.0M | 45.76% |
| FY2019 | $59.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2023 | $127.0M | (5.22%) |
| Jun 2023 | $134.0M | 5.51% |
| Mar 2023 | $127.0M | 0.00% |
| Dec 2022 | $127.0M | 4.96% |
| 15 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| BAX Baxter International Inc. compare | $9.5B |
| SOLV Solventum Corporation compare | $5.3B |
| BLCO Bausch + Lomb Corporation compare | $5.1B |
| AVTR Avantor, Inc. compare | $3.7B |
| TFX Teleflex Incorporated compare | $2.8B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| ATR AptarGroup, Inc. compare | $1.4B |
| RGEN Repligen Corporation compare | $551.0M |
| ALGN Align Technology, Inc. | $127.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement